4-1BB ligand modulates direct and Rituximab-induced NK-cell reactivity in chronic lymphocytic leukemia. | Eur J Immunol;42(3): 737-48, 2012 Mar. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

4-1BB ligand modulates direct and Rituximab-induced NK-cell reactivity in chronic lymphocytic leukemia.

Buechele, Corina; Baessler, Tina; Schmiedel, Benjamin J; Schumacher, Carla E; Grosse-Hovest, Ludger; Rittig, Kilian; Salih, Helmut R.

Affiliation

Buechele C; Department of Hematology, Eberhard Karls University of Tuebingen, Tuebingen, Germany.

Eur J Immunol ; 42(3): 737-48, 2012 Mar.

Article in En | MEDLINE | ID: mdl-22144129

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / Leukemia, Lymphocytic, Chronic, B-Cell / 4-1BB Ligand / Antibodies, Monoclonal, Murine-Derived / Antineoplastic Agents Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Eur J Immunol Year: 2012 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / Leukemia, Lymphocytic, Chronic, B-Cell / 4-1BB Ligand / Antibodies, Monoclonal, Murine-Derived / Antineoplastic Agents Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Eur J Immunol Year: 2012 Document type: Article Affiliation country: Country of publication: